|

Isatuximab SC Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Isatuximab irfc, SAR650984

Pipeline

Phase 2: 1

Top Sponsors

  • Massachusetts General Hospital1

Indications

  • Relapsed Refractory Multiple Myeloma (RRMM)1
  • Relapsed/ Refractory Multiple Myeloma1
  • Cancer1

Boston, Massachusetts1 trial

ELISA in Relapsed/Refractory MM

Massachusetts General Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.